DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NARATRIPTAN

« Back to Dashboard

All Clinical Trials for Naratriptan

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00282165	Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order	Terminated	FPC De Kijvelanden, Poortugaal	Phase 4	2006-11-01	In a double blind randomized clinical trial with cross-over design, treatment using naratriptan will be compared to placebo within a group of 30 convicts with psychiatric disorders such as psychosis or psychopathy with repeated aggressive outbursts resistant to conventional psychopharmacologic and other psychotherapeutic treatment. Hypothesis is that addition of naratriptan to the individual treatment regime reduces aggression -and improves general outcome- as compared to addition of placebo and is well tolerated in this group and under these conditions.
NCT00282165	Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order	Terminated	UMC Utrecht	Phase 4	2006-11-01	In a double blind randomized clinical trial with cross-over design, treatment using naratriptan will be compared to placebo within a group of 30 convicts with psychiatric disorders such as psychosis or psychopathy with repeated aggressive outbursts resistant to conventional psychopharmacologic and other psychotherapeutic treatment. Hypothesis is that addition of naratriptan to the individual treatment regime reduces aggression -and improves general outcome- as compared to addition of placebo and is well tolerated in this group and under these conditions.
NCT00487578	Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction	Terminated	Clinvest	Phase 4	2006-10-01	The purpose of this study is to determine whether naratriptan, a medication approved for treatment of migraine, is effective in the treatment of post traumatic headache associated with cognitive dysfunction.

Clinical Trial Conditions for Naratriptan

Condition Name

Condition Name for Naratriptan
Intervention	Trials
Migraine	4
Migraine Disorders	3
Headache	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Naratriptan
Intervention	Trials
Migraine Disorders	6
Headache	3
Personality Disorders	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Naratriptan

Trials by Country

Trials by Country for Naratriptan
Location	Trials
United States	5
Netherlands	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Naratriptan
Location	Trials
Washington	2
Texas	1
North Carolina	1
Missouri	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Naratriptan

Clinical Trial Phase

Clinical Trial Phase for Naratriptan
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	2
Phase 2	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Naratriptan
Clinical Trial Phase	Trials
Completed	5
Withdrawn	2
Terminated	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Naratriptan

Sponsor Name

Sponsor Name for Naratriptan
Sponsor	Trials
GlaxoSmithKline	4
Roxane Laboratories	2
Ache Laboratorios Farmaceuticos S.A.	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Naratriptan
Sponsor	Trials
Industry	9
Other	4

Export unavailable in trial.
Subscribe for complete access.